Issue 7, 2021, Issue in Progress
From the journal:

RSC Advances

Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways

Laura Fishera  

a Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, UK
E-mail: advances-rsc@rsc.org

Abstract

Retraction of ‘Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways’ by Hongling Yang et al., RSC Adv., 2018, 8, 21816–21822, DOI: 10.1039/C8RA01674G.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D1RA90018H
Article type
Retraction
Submitted
12 Jan 2021
Accepted
12 Jan 2021
First published
20 Jan 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 4165-4165

Permissions

Request permissions

Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways

L. Fisher, RSC Adv., 2021, 11, 4165 DOI: 10.1039/D1RA90018H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements